Nitric oxide/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion

Cellular Microbiology

Volumn 12, Issue 1, 2010, Pages 67-83

  Mittal, Rahul ^a   Prasadarao, Nemani V ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ESCHERICHI COLI K1 RECEPTOR; ESCHERICHIA COLI PROTEIN; GLYCOPROTEIN GP 96; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OUTER MEMBRANE PROTEIN A; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN;

ARTICLE; BACTERIAL COLONIZATION; BRAIN CELL; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICROVASCULARIZATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; BIOLOGICAL MODEL; BRAIN; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ESCHERICHIA COLI;

BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; CYCLIC GMP; ENDOTHELIAL CELLS; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77649218825     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2009.01379.x     Document Type: Article

References (62)

1. Antonova G, Lichtenbeld H, Xia T, Chatterjee A, Dimitropoulou C, Catravas JD. Functional significance of hsp90 complexes with NOS and sGC in endothelial cells. Clin Hemorheol Microcirc 2007, 37:19-35.
2. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001, 2:907-916.
3. Boje KM. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res 1996, 720:75-83.
4. Boveri M, Kinsner A, Berezowski V, Lenfant AM, Draing C, Cecchelli R. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 2006, 137:1193-1209.
5. Bratasz A, Kuter I, Konior R, Goscinski I, Lukiewicz S. Nitric oxide as a prognostic marker for neurological diseases. Antioxid Redox Signal 2004, 6:613-617.
6. Burgner D, Rockett K, Kwiatkowski D. Nitric oxide and infectious diseases. Arch Dis Child 1999, 81:185-188.
7. Cary SP, Winger JA, Derbyshire ER, Marletta MA. Nitric oxide signaling: no longer simply on or off. Trends Biochem Sci 2006, 31:231-239.
8. Chakravortty D, Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 2003, 5:621-627.
9. Chan ED, Chan J, Schluger NW. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am J Respir Cell Mol Biol 2001, 25:606-612.
10. Constantin D, Cordenier A, Robinson K, Ala'Aldeen DAA, Murphy S. Neisseria meningitidis-induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase. J Neurochem 2004, 89:1166-1174.
11. Coureuil M, Mikaty G, Miller F, Lécuyer H, Bernard C, Bourdoulous S. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 2009, 325:83-87.
12. Denninger JW, Marletta MA. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1999, 1411:334-350.
13. Derbyshire ER, Marletta MA. Biochemistry of soluble guanylate cyclase. Handb Exp Pharmacol 2009, 121:17-31.
14. Engelhardt B. Development of the blood-brain barrier. Cell Tissue Res 2003, 314:119-129.
15. Golombek DA, Agostino PV, Plano SA, Ferreyra GA. Signaling in the mammalian circadian clock: the NO/cGMP pathway. Neurochem Int 2004, 45:929-936.
16. Hattor Y, Kasai K, Akimoto K, Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun 1997, 233:375-379.
17. Hoffmann O, Zweigner J, Smith SH, Freyer D, Mahrhofer C, Dagand E. Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide. Infect Immun 2006, 74:5058-5066.
18. Hou Y, Lascola J, Dulin NO, Ye RD, Browning DD. Activation of cGMP-dependent protein kinase by protein kinase C. J Biol Chem 2003, 278:16706-16712.
19. Jaworowicz DJ, Korytko PJ, Singh LS, Boje KM. Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis. Brain Res Bull 1998, 46:541-546.
20. Ji JY, Diamond SL. Exogenous nitric oxide activates the endothelial glucocorticoid receptor. Biochem Biophys Res Commun 2004, 318:192-197.
21. Khan SA, Strijbos PJ, Everest P, Moss D, Stratford R, Mastroeni P. Early responses to Salmonella typhimurium infection in mice occur at focal lesions in infected organs. Microb Pathog 2001, 30:29-38.
22. Kim KS. Pathogenesis of bacterial meningitis: from bacteremia to neuronal injury. Nat Rev Neurosci 2003, 4:376-385.
23. Kim BY, Kang J, Kim KS. Invasion processes of pathogenic Escherichia coli. Int J Med Microbiol 2005, 295:463-470.
24. Krumenacker JS, Murad F. NO-cGMP signaling in development and stem cells. Mol Genet Metab 2006, 87:311-314.
25. Lahiri A, Das P, Chakravortty D. Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes Infect 2008, 10:1166-1174.
26. Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 1999, 13:527-548.
27. Maruvada R, Argon Y, Prasadarao NV. Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion. Cell Microbiol 2008a, 10:2326-2338.
28. Maruvada R, Blom AM, Prasadarao NV. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 2008b, 124:265-276.
29. Mayhan WG. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 2000, 866:101-108.
30. Mittal R, Sharma S, Chhibber S, Harjai K. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog 2008, 45:323-330.
31. Murawska-Ciałowicz E, Szychowska Z, Trbusiewicz B. Nitric oxide production during bacterial and viral meningitis in children. Int J Clin Laboratory Res 2000, 30:127-131.
32. Murphy BA, Fakira KA, Song Z, Beuve A, Routh VH. AMP-activated Protein Kinase (AMPK) and Nitric Oxide (NO) regulate the glucose sensitivity of ventromedial hypothalamic (VMH) glucose-inhibited (GI) neurons: Am J Physiol Cell Physiol. 2009, 297:C750-758.
33. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
34. Panjwani NN, Popova L, Srivastava PK. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol 2002, 168:2997-3003.
35. Papapetropoulos A, Zhou Z, Gerassimou C, Yetik G, Venema RC, Roussos C. Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding. Mol Pharmacol 2005, 68:1133-1141.
36. Pearce WJ, Williams JM, White CR, Lincoln TM. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries. J Appl Physiol 2009, 107:192-199.
37. Petrov AM, Giniatullin AR, Sitdikova GF, Zefirov AL. The role of cGMP-dependent signaling pathway in synaptic vesicle cycle at the frog motor nerve terminals. J Neurosci 2008, 28:13216-13222.
38. Polin RA, Harris MC. Neonatal bacterial meningitis. Semin Neonatol 2001, 6:157-172.
39. Poulos TL. Soluble guanylate cyclase. Curr Opin Struct Biol 2006, 16:736-743.
40. Prasadarao NV. Identification of Escherichia coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun 2002, 70:4556-4563.
41. Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, Kim KS. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun 1996, 64:146-153.
42. Prasadarao NV, Srivastava PK, Rudrabhatla RS, Kim KS, Huang SH, Sukumaran SK. Cloning and expression of the Escherichia coli K1 outer membrane protein A receptor, a gp96 homologue. Infect Immun 2003, 71:1680-1688.
43. Remer KA, Jungi TW, Fatzer R, Täuber MG, Leib SL. Nitric oxide is protective in listeric meningoencephalitis of rats. Infect Immun 2001, 69:4086-4093.
44. Selvaraj SK, Periandythevar P, Prasadarao NV. Outer membrane protein A of Escherichia coli K1 selectively enhances the expression of intercellular adhesion molecule-1 in brain microvascular endothelial cells. Microbes Infect 2007, 9:547-557.
45. Shin S, Lu G, Cai M, Kim KS. Escherichia coli outer membrane protein A adheres to human brain microvascular endothelial cells. Biochem Biophys Res Commun 2005, 330:1199-1204.
46. Stenger S, Donhauser N, Thuring H, Röllinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996, 183:1501-1514.
47. Stins MF, Prasadarao NV, Ibric L, Wass CA, Luckett P, Kim KS. Binding characteristics of S fimbriated Escherichia coli to isolated brain microvascular endothelial cells. Am J Pathol 1994, 145:1228-1236.
48. Sukumaran SK, Prasadarao NV. Regulation of protein kinase C in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J Biol Chem 2002, 277:12253-12262.
49. Sukumaran SK, Prasadarao NV. Escherichia coli K1 invasion increases human brain microvascular endothelial cell monolayer permeability by disassembling vascular-endothelial cadherins at tight junctions. J Infect Dis 2003, 188:1295-1309.
50. Sukumaran SK, Quon MJ, Prasadarao NV. Escherichia coli K1 internalization via caveolae requires caveolin-1 and protein kinase C alpha interaction in human brain microvascular endothelial cells. J Biol Chem 2002, 277:50716-50724.
51. Sukumaran SK, McNamara G, Prasadarao NV. Escherichia coli K1 interaction with human brain microvascular endothelial cells triggers phospholipase C-gamma1 activation downstream of phosphatidylinositol 3-kinase. J Biol Chem 2003, 278:45753-45762.
52. Suzuki Y, Fujii S, Tominaga T, Yoshimoto T, Fujii S, Akaike T. Direct evidence of in vivo nitric oxide production and inducible nitric oxide synthase mRNA expression in the brain of living rat during experimental meningitis. J Cereb Blood Flow Metab 1999, 19:1175-1178.
53. Tunbridge AJ, Stevanin TM, Lee M, Marriott HM, Moir JWB, Read RC, Dockrell DH. Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms. Infect Immun 2006, 74:729-733.
54. Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 1993, 6:118-136.
55. Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 2003, 285:H669-H678.
56. Winter S, Konter J, Scheler S, Lehmann J, Fahr A. Permeability changes in response to NONOate and NONOate prodrug derived nitric oxide in a blood-brain barrier model formed by primary porcine endothelial cells. Nitric Oxide 2008, 18:229-239.
57. Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol 2004, 190:446-455.
58. Woods ME, Olano JP. Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells. J Clin Immunol 2008, 28:174-185.
59. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
60. Xie Y, Kim KJ, Kim KS. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol Med Microbiol 2004, 42:271-279.
61. Yoshida M, Xia Y. Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J Biol Chem 2003, 278:36953-36958.
62. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.